Haemonetics reported $2.41B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Cerus USD 221.86M 6.67M Dec/2025
Cooper Companies USD 12.67B 191.1M Jun/2026
Fresenius EUR 42.24B 401M Sep/2026
Fresenius Medical Care EUR 31.45B 155.97M Sep/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Haemonetics USD 2.41B 45.2M Sep/2026
ICU Medical USD 3.94B 27.48M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Neogen USD 3.3B 42.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Quidel USD 5.78B 66M Sep/2026
ResMed USD 8.21B 754.14M Sep/2026
STAAR Surgical USD 485.16M 9.95M Sep/2026
Steris USD 10.71B 22.5M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Terumo JPY 2.24T 135.2B Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
US Physical Therapy USD 1.3B 46.87M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026